NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Medicines Update

For all prescribers and health professionals both in primary care and the acute sector.

News and information blog from ADTC covering clinical topics for all sectors of the NHS.

All editions of PostScript (the previous name for Medicines Update) from 2011 onwards have been added to this site.  Click here for an index to all previous editions.  If you would like a copy of a previous edition, please contact  medicines.update@ggc.scot.nhs.uk

Safety Update: Domperidone (July 2014)

Posted: July 07, 2014.
Category - Medicines Update

The MHRA has recently recommended changes to the use of domperidone, including restricting the dose and duration of use, to minimise the known risks of ...

Read More...

PPIs and Clostridium Difficile (July 2014)

Posted: July 07, 2014.
Category - Medicines Update

Clostridium difficile infection (CDI) is one of the important healthcare associated infection in Scottish hospitals. It is life-threatening (reported mortality rate 10 - 30%) and has the potential for person to person spread ...

Read More...

Drug induced photosensitivity (July 2014)

Posted: July 07, 2014.
Category - Medicines Update

At this time of year, with improving weather and the peak holiday period, the incidence of reactions to sun increase. Some medicines cause particular problems. Dr Paula E Beattie, Consultant Dermatologist at the Royal Hos...

Read More...

ADTC decisions and other updates

Posted: July 07, 2014.
Category - Medicines Update

  ADTC decisions are here including: The following medicines were added to the Adult Total F...

Read More...

PostScript 82 PDF (July 2014)

Posted: July 07, 2014.
Category - Medicines Update

This edition can be accessed in PDF format here and contains articles on:   Dual Antiplatelet Therapy Safety Update: Do...

Read More...

PostScript 81 PDF (May 2014)

Posted: May 05, 2014.
Category - Medicines Update

This edition can be accessed in PDF format here and contains articles on:   Novel oral anticoagulant update New oral products for multiple sclerosis Tramadol to become controlled drug ...

Read More...

Novel Oral Anticoagulants (NOACs): update

Posted: May 05, 2014.
Category - Medicines Update
Tagged with - Anticoagulants

  Inclusion of the NOACs (dabigatran, rivaroxaban, apixaban) on the NHSGGC Formulary is established for existing patients with non-valvular atrial fibrillation (AF) who are intolerant of, or poor...

Read More...

New oral therapies for Multiple Sclerosis

Posted: May 05, 2014.
Category - Medicines Update
Tagged with - SMC

It is exciting times in the treatment of Multiple Sclerosis (MS) with the approval of two new oral therapies for the treatment of the relapsing remitting form of the disease; dimethyl fumarate and teriflunomide. There has bee...

Read More...

Tramadol and changes to Controlled Drug Legislation

Posted: May 05, 2014.
Category - Medicines Update
Tagged with - Opioids

Tramadol to be a Schedule 3 Controlled Drug The Home Office has announced changes to CD classification for a number of drugs which should be implemented from 10th June ...

Read More...

Safety updates: Nitrofurantoin, contraceptives

Posted: May 05, 2014.
Category - Medicines Update
Tagged with - Antimicrobial Prescribing Medication incidents

Nitrofurantoin in renal impairment The MHRA has intimated plans to amend the contraindication against use of nitrofurantoin in renal impairment from CrCl <60 mL/min to eGFR &l...

Read More...